Cure For Macular Degeneration Stem Cells

Humans are a vision oriented species.

Cure for macular degeneration stem cells.

Again this will further reduce eyesight by increasing pressure on the eye. Macular degeneration is the name given to the usually slow loss of vision. On the other hand the potential benefits of stem cell treatments for macular degeneration are huge. It cannot cure macular degeneration or stop future damage but it may help to preserve the vision people have now.

Yes we possess five full senses but our eyes are the most important of our sensory organs. Doctors are also experimenting with the use of stem cells to assist with macular degeneration. Patients who were the first to receive a new treatment for wet age related macular degeneration amd derived from stem cells in 2015 have maintained improvements in their vision five years on. In 2018 it was reported that the first patients to receive a new treatment derived from stem cells had gone from not being able to read at all even.

A stem cell is a type of cell that is undifferentiated meaning that it can become any type of cell within the body. 23 2012 two legally blind women with macular degeneration are the first people ever to get new retina cells grown from human embryonic stem cells. One patient has dry macular. In a dramatic development research is underway to use induced pluri potent stem cells for the treatment of macular degeneration because these cells would be made from the same person eliminating the need for immuno suppressive drugs as well as any religious objections.

In fact a major percentage of our brains is allocated to processing information from our eyes. Stem cell treatment for macular degeneration. In the experimental therapy a specially engineered sheet of stem cells is transplanted into the back wall of the eye to replace a layer of cells destroyed by age related macular degeneration amd. Patients with age related macular degeneration amd often ask whether stem cell therapy might improve their vision now or at some point in the future.

Researchers in california expect to launch a phase 2 clinical trial of stem cell therapy for age related macular degeneration this year while a team from the national institutes of health is not. Because stem cells are capable of endless self replication there is a danger that they may grow out of control.